N(6)-cyclopentyladenosine,
N6-cyclopentyladenosine,
N6-Cyclopentyladenosine,
41552-82-3,
n-cyclopentyladenosine,
(2R,3R,4S,5R)-2-(6-(Cyclopentylamino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol,
Cyclopentyladenosine,
CHEMBL68738,
MLS000028368,
N(6)-Cyclopentyladenosine,
SMR000058639,
(2R,3R,4S,5R)-2-[6-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol,
Adenosine, N-cyclopentyl-,
UNII-7LG47VG1ID,
7LG47VG1ID,
N6-CyclopentylAdo,
n-cyclopentyl-adenosine,
n6-cyclopentyl-adenosine,
AC1LCWG1,
Opera_ID_1056,
GTPL380,
MLS001077332,
MLS002153196,
SCHEMBL120481,
N6-cyclopentyladenosine (CPA),
N6-Cyclopentyladenosine, solid,
cid_657378,
BDBM25400,
CTK1D5898,
SQMWSBKSHWARHU-SDBHATRESA-N,
HMS2232M15,
HMS3676D12,
ZINC3995996,
5720AB,
MFCD00036845,
PDSP1_001069,
PDSP2_001053,
AKOS016009596,
NCGC00023909-04,
NCGC00023909-05,
NCGC00023909-06,
AC-27402,
AJ-47612,
LS-15119,
ST24026157,
J-523544,
(2R,3R,4S,5R)-2-[6-(cyclopentylamino)-9H-purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol,
3GU,
CCPA,
D03RFA,
C15H21N5O4,
CID657378,
C15-H21-N5-O4,
CPA,
C048599,